Biotechnology

Advancing targeted therapies for antimicrobial resistance

PALDARA develops next-generation bacteriophage therapeutics and advanced biomaterial delivery platforms designed to prevent and treat multidrug-resistant infections with precision.

Explore Research

View Pipeline

Mission

Engineering precision antibacterial platforms

Paldara Pharmaceuticals is focused on translating bacteriophage science into clinically relevant therapies that address the growing global burden of antimicrobial resistance.

Our proprietary phage-hydrogel approach is designed to deliver highly targeted antibacterial activity while reducing dependence on conventional antibiotics and supporting better therapeutic outcomes.

About PALDARA

Scientist handling a sample in a modern pharmaceutical laboratory

Focus Areas

Built for scientific progress

Phage Therapeutics

Developing bacteriophage-based therapies engineered for targeted activity against multidrug-resistant bacterial infections.

Research

Biomaterial Delivery

Advancing hydrogel-enabled delivery systems that improve localization, stability, and therapeutic performance.

Pipeline

Translational Development

Aligning discovery, formulation, and preclinical strategy to move promising platforms toward real-world clinical impact.

Contact

Why It Matters

Responding to a global resistance challenge

AMR demands new therapeutic strategies. PALDARA is building targeted antibacterial solutions that combine biological specificity with advanced delivery science to support the future of infection care.

Modern microscope with digital imaging system in a biological research laboratory

Targeted

Phage-based therapeutic approach

Advanced

Hydrogel delivery platform

Focused

On multidrug-resistant infections

Partner with PALDARA

Connect with our team to discuss research collaboration, scientific inquiries, or partnership opportunities in next-generation anti-infective development.

Start a conversation

We welcome inquiries from research partners, investors, and organizations interested in innovative approaches to antimicrobial resistance.